The mechanism by which GLP-1 agonists reduce alcohol intake in humans is currently unknown, though a recent RCT reported reduced alcohol cue reactivity in the nucleus accumbens (NAc), a key region associated with alcohols rewarding properties, after treatment with the GLP-1 agonist Exenatide 11
Protein needs should be individualized
& Fadool, D
For a product that claims to deliver pharmaceutical compounds through your skin, the absence of basic business transparency is alarming
Prevounce helps healthcare organizations, including primary care providers, specialty practices, federally qualified health centers (FQHC), and rural health clinics (RHC) , operationalize RPM in a way that balances clinical value, financial performance, and compliance